Incurable Cancer DiseasesESPILNCT00495482
Incurable Ill Patients Attitudes Towards Euthanasia and Assisted Suicide
An observational study of Incurable Cancer Diseases and Other Incurable Diseases, run by Klinikum St. Georg gGmbH at 1 site in Germany.
Trial summary
Euthanasia and assisted dying are of growing interest for patients with incurable diseases. The possible methods are widely discussed by patient-societies, physicians, lawyers, theologians and philosophers. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Incurable Cancer Diseases, Other Incurable Diseases
- How many people
- 200 participants
- Where
- 1 siteGermany
- Study dates
- Sep 2006to Jan 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with incurable illness
Who may be able to join
- Age >= 18 years
- Incurable illness
- Mental state thet allows to answer a questionnaire
Who cannot join
- Somnolence
- Low mental state
- Curable disease
- Depression with danger of acute suicide
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Incurable Ill Patients Attitudes to Euthanasia and Assisted Suicide: A Prospective, Multi-Centre Trial in Palliative Care Units in Saxony
Euthanasia and assisted dying are of growing interest for patients with incurable diseases. The possible methods are widely discussed by patient-societies, physicians, lawyers, theologians and philosophers. During the last years several opinion-polls were conducted with healthy people or medical stuff, but no surveys were conducted to get the attitude of incurable ill patients.
The hypothesis of the investigators' study is: "Palliative Care Medicine is a better option for incurable ill patients than an assisted suicide."
- Keywords
- Euthanasia, Assisted Suicide, Assisted Dying, Palliative Care Medicine
- Medical subject headings
- Suicide, Assisted
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| 1 | Patients receiving palliative care due to incurable illness |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patients intention to assisted suicide
Measured: up to four weeks after beginning of palliative treatment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jul 2007 (estimated)
- Study startSep 2006
- Study completionJan 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Incurable Cancer DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Klinikum St. Georg gGmbH
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Armin Sablotzki, MD, Klinikum St. Georg gGmbH
- Investigators
- Armin R Sablotzki, MD, Principal investigator, Klinikum St. Georg Leipzig, Clinics of Anesthesiology, Critical Care and Pain TherapyMatthias Thieme, MD, Study director, Klinikum St. Georg Leipzig, Clinics of Anesthesiology, Critical Care and Pain Therapy
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00495482
- Sponsor's protocol ID
- BR-14/06-1
- Other IDs
- BR-14/06-1
- Acronym
- ESPIL
- Status last verified
- Nov 2012
- First submitted
- 2 Jul 2007
- Last updated
- 14 Nov 2012
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Nov 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Incurable Ill Patients Attitudes to Euthanasia and Assisted Suicide: A Prospective, Multi-Centre Trial in Palliative Care Units in Saxony
- ClinicalTrials.gov ID
- NCT00495482
- Acronym / sponsor ID
- ESPIL / BR-14/06-1
- Keywords
- Euthanasia, Assisted Suicide, Assisted Dying, Palliative Care Medicine
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Klinikum St. Georg gGmbHUniversity, hospital or other
- Study start
- Sep 2006
- Study completion
- Jan 2010 (actual)
- First posted
- 3 Jul 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Euthanasia and assisted dying are of growing interest for patients with incurable diseases. The possible methods are widely discussed by patient-societies, physicians, lawyers, theologians and philosophers. During the last years several opinion-polls were conducted with healthy people or medical stuff, but no surveys were conducted to get the attitude of incurable ill patients.
The hypothesis of the investigators' study is: "Palliative Care Medicine is a better option for incurable ill patients than an assisted suicide."
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 1 | – | –Patients receiving palliative care due to incurable illness |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with incurable illness
Key inclusion criteria (3 listed)
- Age >= 18 years
- Incurable illness
- Mental state thet allows to answer a questionnaire
Key exclusion criteria (4 listed)
- Somnolence
- Low mental state
- Curable disease
- Depression with danger of acute suicide
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Patients intention to assisted suicide
Time frame: up to four weeks after beginning of palliative treatment
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Nov 2012.
- Homepage of the study siteLink provided by the sponsor.
Related trials for Incurable Cancer Diseases
Active, not recruitingPhase 2
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
Anxiety, Depression
Not yet recruitingPhase 3
A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma
Hepatocellular Carcinoma
Recruiting
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
Lung Carcinoma, Metastatic Lung Carcinoma
Active, not recruitingPhase 2
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
IPMN, IPMN, Pancreatic
Active, not recruitingPhase 1
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers
Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Armin R Sablotzki, MD principal investigator
Klinikum St. Georg Leipzig, Clinics of Anesthesiology, Critical Care and Pain Therapy
Matthias Thieme, MD study director
Klinikum St. Georg Leipzig, Clinics of Anesthesiology, Critical Care and Pain Therapy
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Incurable Cancer Diseases and Other Incurable Diseases, run by Klinikum St. Georg gGmbH at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Nov 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patients intention to assisted suicide (time frame: up to four weeks after beginning of palliative treatment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2012.